Retatrutide activates GLP-1, GIP, and glucagon receptors, making it a triple agonist and the most receptor-diverse obesity compound currently in clinical development
its a dynamic treatment thats optimized through ongoing assessment
Quick Facts at a Glance Brand Micro Ingredients Country of Origin USA Product Type TUDCA liver wellness supplement Pack Size 240 capsules Serving Size 3 capsules Servings 80 servings per container TUDCA 300 mg tauroursodeoxycholic acid Proprietary Blend 1,700 mg botanical and antioxidant blend Key Blend Ingredients Milk thistle, dandelion, artichoke, NAC, taurine, glutathione Capsule Type Gelatin capsule Free From Wheat, gluten, soy, dairy, and tree nuts Best For Liver, bile-flow, antioxidant, digestive and detox-routine support Frequently Asked Questions What is Micro Ingredients TUDCA 2,000 mg used for
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Singh R., Singh S., Parihar P., Mishra R.K., Tripathi D.K., Singh V.P., Chauhan D.K., Prasad S.M
Everyday Wellness & Vitality For busy professionals, parents, and travelers Explore Services Immune Support & Recovery Strengthen immunity, recover from illness or travel Explore Services Radiant Skin & Healthy Aging Glow, youthful skin, hair, and nails Explore Services Performance & Muscle Recovery Endurance, athletic performance, faster recovery Explore Services Mental Clarity & Focus Sharper thinking, memory, and cognitive support Explore Services Stress Relief & Emotional Wellness Relaxation, mood balance, and calm Explore Services Hydration & Recovery Reset Travel fatigue, jet lag, dehydration recovery Explore Services Weight Loss & Metabolism Physician-guided weight loss support Explore Services Pain Relief & Recovery Chronic inflammation and muscle soreness relief Explore Services Digestive Wellness & Gut Health Nutrient absorption and microbiome support Explore Services The Glutathione Difference Known as the "master antioxidant," Glutathione is naturally produced in your body but depletes with age, stress, and toxin exposure
doi:10.1016/j.jconrel.2011.01.030
